Search

everythinglearnresearchcommunity

for

Search:↓

Tailored nonsurgical cosmetic procedures are crucial for safely treating diverse skin types, especially skin of color.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Microneedling is an effective and safe method for improving skin conditions like acne scars and wrinkles.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Visible light can improve skin disorders and hair loss, but more research is needed to understand long-term effects.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Early treatment of PCOS is crucial for better health and quality of life.

Derma rollers show promise for skin improvement and drug delivery, but more research is needed on their safety and effectiveness.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Combining nanotechnology with herbal medicine may improve PCOS treatment.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Microbes might play a role in vitiligo.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

Histone modification is key in treating chronic inflammatory skin diseases.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.